Keeping Current
by Medscape Podcasts
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 10 chart positions in 10 markets.
By chart position
- 🇰🇷KR · Medicine#1101K to 10K
- 🇹🇭TH · Medicine#3510K to 30K
- 🇬🇷GR · Medicine#4010K to 30K
- 🇹🇷TR · Medicine#753K to 10K
- 🇳🇬NG · Medicine#933K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
15K to 53K🎙 ~2x weekly·597 episodes·Last published 2mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
30K to 105K🇹🇭29%🇬🇷29%🇰🇷10%+7 more - Active Followers
Loyal subscribers who consistently listen
8.8K to 32K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Not detected.
Recent guests
Recent episodes
Pharmacological and Combination Interventions for Nicotine Cessation
Jun 30, 2026
33m 24s
Is Normalizing Hemostasis an Achievable Goal in Hemophilia A?
Jun 26, 2026
29m 31s
The Top 5 Errors in Transthyretin Amyloid Cardiomyopathy Management
Jun 26, 2026
17m 41s
Better Drying? Longer Lasting? Second-Generation Anti-VEGF Therapies in Clinical Practice
Jun 23, 2026
37m 03s
Shaping the Future of Precision Oncology: Biomarker-Driven Care for Tumor-Agnostic Therapies
Jun 17, 2026
23m 21s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/30/26 | nicotine cessationpharmacological interventions+3 | — | Medscape Podcasts | — | nicotinecessation+4 | — | 33m 24s | ||
| 6/26/26 | hemostasishemophilia A+3 | — | Hemophilia AMedscape Podcasts | — | hemostasishemophilia A+3 | — | 29m 31s | ||
| 6/26/26 | transthyretin amyloid cardiomyopathypatient care+3 | Dr. García-PaviaDr. Sperry | Medscapetransthyretin amyloid cardiomyopathy | — | transthyretin amyloid cardiomyopathyATTR-CM+3 | — | 17m 41s | ||
| 6/23/26 | anti-VEGF therapiesclinical practice+3 | — | second-generation anti-VEGF therapiesMedscape Podcasts | — | anti-VEGFtherapies+3 | — | 37m 03s | ||
| 6/17/26 | precision oncologytumor-agnostic therapies+3 | — | Medscape PodcastsShaping the Future of Precision Oncology: Biomarker-Driven Care for Tumor-Agnostic Therapies | — | precision oncologytumor-agnostic+3 | — | 23m 21s | ||
| 6/17/26 | Alagille syndromeIBAT inhibitors+3 | — | IBAT inhibitorsMedscape | Alagille syndrome | Alagille syndromeIBAT inhibitors+3 | — | 21m 55s | ||
| 6/5/26 | Chronic Inflammatory Demyelinating Polyradiculoneuropathypatient care+3 | — | Medscape PodcastsChronic Inflammatory Demyelinating Polyradiculoneuropathy | — | CIDPdemyelinating+4 | — | 26m 15s | ||
| 6/2/26 | hemophilia Ahemostasis+3 | — | FVIIINon-Factor Replacement+1 | — | hemophilia AFVIII+3 | — | 29m 13s | ||
| 6/1/26 | depressionneurological diseases+3 | — | Medscape Podcasts | — | depressionneurological diseases+3 | — | 22m 29s | ||
| 5/21/26 | myasthenia gravisnovel therapies+3 | — | MedscapeWhat Lies Beneath Generalized Myasthenia Gravis | — | myasthenia gravistherapies+3 | — | 31m 16s |
Showing 10 of 10
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Keeping Current
Peaked at #35 in TH, currently #35 in TH.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| TH | — | #35 | #35 | — |
| GR | — | #40 | #40 | — |
| TR | — | #75 | #75 | — |
| NG | — | #93 | #93 | — |
| IL | — | #106 | #106 | — |
| South Korea | — | #110 | #110 | — |
| VN | — | #121 | #121 | — |
| New Zealand | — | #127 | #127 | — |
| MY | — | #131 | #131 | — |
| Finland | — | #150 | #150 | — |
Chart Positions
10 placements across 10 markets.
Chart Positions
10 placements across 10 markets.